The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine the safety and effect on pulmonary function of 14
days of inhaled L-arginine versus placebo administered over a period of 14 days in a cohort
of CF patients.